# MOASIC: Mobile lung Screening evaluation and outComes

> **NIH VA I50** · RALPH H JOHNSON VA MEDICAL CENTER · 2024 · —

## Abstract

Background: Lung cancer kills more Veterans annually than the next three cancers combined. Lung cancer
screening (LCS) with low-dose CT reduces lung cancer mortality through early detection, yet only 2.8% of
eligible Veterans have been screened. The Lung Precision Oncology Program (LPOP) was developed to
expand the availability of high quality LCS across the VA enterprise. Through our work done through a QUERI
Rapid Project Proposal and that of others, drive time distance to a VA CT scanner has been shown to be a
barrier to LCS, especially for rural Veterans. VISNs 7 and 9 will be implementing mobile LCS (mLCS) to
address this known barrier. We hypothesize that mLCS will increase LCS reach including 1) the proportion of
Veterans offered LCS by providers, 2) uptake of LCS among eligible Veterans, and 3) adherence to
recommended follow-up LCS among Veterans utilizing mLCS. Significance: This evaluation will determine the
impact of mLCS on the offering, acceptance, and adherence to LCS by eligible Veterans. Identify facilitators
and barriers to mLCS implementation and determine start up, maintenance and overall cost efficacy.
Innovation & Impact: The evaluation of implementation of mLCS in the Veterans Health Administration (VHA)
is innovative and will inform mLCS implementation for other VHA sites and beyond VHA. Understanding
provider and Veteran perceptions of mLCS, barriers and facilitators to implementation, estimates of Veteran
demand, and best technology practices will provide valuable information to be included in a checklist for
replication and implementation across VHA. Ultimately this will impact and ensure mortality reduction of lung
cancer through early detection. Specific Aims: 1. Pre-implementation: Understand the development of mLCS,
assess provider staff perceptions, anticipated barriers and facilitators to implementation, and engage Veterans
to optimize implementation and messaging.2. Implementation Outcomes: Conduct a mixed-methods evaluation
of the reach (offering, uptake, and adherence) and acceptability of mLCS implementation. 3. Clinical/Health
Outcomes: Evaluate the clinical impact of and satisfaction with mLCS on the offering of, acceptance by, and
adherence to LCS by eligible Veterans. 4. Economic impacts: Assess start-up and continuing costs of mLCS
programs including implementation support costs and compare cost of mLCS compared to traditional care and
community care. Methodology: A mixed methods approach to the planning, delivery and evaluation (formative
and summative) of mLCS implementation is proposed. The Reach, Effectiveness, Adoption, Implementation,
Maintenance (RE-AIM) Framework will be used for planning and summative evaluation. In addition, the
Practical Robust Implementation and Sustainability Model (PRISM) will be utilized for formative evaluation at
each Community-Based Outpatient Clinic (CBOC) location utilizing mLCS. Data will be collected through
quantitative and qualitative assessments including surveys ...

## Key facts

- **NIH application ID:** 10863022
- **Project number:** 1I50HX003770-01A1
- **Recipient organization:** RALPH H JOHNSON VA MEDICAL CENTER
- **Principal Investigator:** Nichole Tripician Tanner
- **Activity code:** I50 (R01, R21, SBIR, etc.)
- **Funding institute:** VA
- **Fiscal year:** 2024
- **Award amount:** —
- **Award type:** 1
- **Project period:** 2024-04-01 → 2027-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10863022

## Citation

> US National Institutes of Health, RePORTER application 10863022, MOASIC: Mobile lung Screening evaluation and outComes (1I50HX003770-01A1). Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/grant/nih/10863022. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*